Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Journal of Acquired Immune Deficiency Syndromes (1999)|November 19, 2015
Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST TrialAndrew Kambugu, Jennifer Thompson, James Hakim, et al.
Plos One|May 7, 2013
Neurocognitive function in HIV infected patients on antiretroviral therapyAlan Winston, Alejandro Arenas-Pinto, Wolfgang Stöhr, et al.
Antiviral Therapy|October 13, 2017
HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in AfricaAnne Hoppe, Marina Giuliano, Abbas Lugemwa, et al.
The Lancet. HIV|October 2, 2015
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trialNicholas I Paton, Wolfgang Stöhr, Alejandro Arenas-Pinto, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trialMeera Gurumurthy, Rupangi Verma, Claire M Naftalin, et al.
Antiviral Therapy|March 24, 2020
Genital secretion HIV RNA shedding in HIV-positive patients on ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT TrialAlejandro Arenas-Pinto, Wolfgang Stöhr, Saye Khoo, et al.
International Journal of STD & AIDS|August 18, 2017
Significant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe-Africa Research Network for the Evaluation of Second-line Therapy trialJane N Wanyama, Maria S Nabaggala, Bonnie Wandera, et al.
Eclinicalmedicine|February 16, 2024
Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)Nicholas I Paton, Wolfgang Stöhr, Alejandro Arenas-Pinto, et al.
Atherosclerosis|June 12, 2009
Lipoprotein particle subclasses, cardiovascular disease and HIV infectionDaniel A Duprez, Lewis H Kuller, Russell Tracy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2017
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysisAlexander J Stockdale, Matthew J Saunders, Mark A Boyd, et al.
Pageof 10